Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
Table 1
Correlation between lower genital tract pathogens and cervical lesions.
Variable
≤LSIL (n = 543)
≥HSIL (n = 339)
value
ORadjust (95% CI)
valueadjust
Age
43.13 ± 10.321
45.79 ± 8.791
0.001a
—
—
Age
≥50
92 (16.9)
98 (28.9)
0.001b
0.600
0.173
<50
451 (83.1)
241 (71.1)
(0.288–1.251)
Menopause
Yes
121 (22.3)
146 (43.1)
0.001b
3.503
0.001
No
422 (77.7)
193 (56.9)
(1.797–6.826)
HPV
Positive
162 (29.8)
318 (93.8)
0.018b
4.786
0.006
Negative
381 (70.2)
21 (6.2)
(1.558–14.709)
HR-HPV
Positive
148 (27.3)
312 (92.0)
0.001b
5.755
0.001
Negative
395 (72.7)
27 (8.0)
(2.033–16.294)
LR-HPV
Positive
14 (2.6)
6 (1.8)
0.433b
—
—
Negative
529 (97.4)
333 (98.2)
Pathogenic bacteria
Positive
93 ( 17.1)
137 (40.4)
0.001b
2.277
<0.001
Negative
450 (82.9)
202 (59.6)
(1.510–3.434)
U. urealyticum
Positive
60 (11.0)
101 (29.8)
0.001b
2.302
<0.001
Negative
483 (89.0)
238 (70.2)
(1.463–3.621)
M. hominis
Positive
32 (5.9)
29 (8.6)
0.130b
—
—
Negative
511 (94.1)
310 (91.4)
C. trachomatis
Positive
26 (4.8)
68 (20.1)
0.001b
3.066
<0.001
Negative
517 (95.2)
271 (79.9)
(1.672–5.623)
a value for Student’s t-test; b value for χ2 test; —: not applicable; adjust: after adjustment for age, menopausal status, and other pathogens. ≤LSIL: normal or low-grade squamous intraepithelial lesion; ≥HSIL: high-grade squamous intraepithelial lesion or cervical squamous cell carcinoma; HR-HPV: high-risk human papillomavirus; LR-HPV: low-risk human papillomavirus.